Initial Biomedical Study of Turbidity Suppression by Optical Phase Conjugation
Project Number3R21EB008866-02S1
Contact PI/Project LeaderYANG, CHANGHUEI
Awardee OrganizationCALIFORNIA INSTITUTE OF TECHNOLOGY
Description
Abstract Text
DESCRIPTION (provided by applicant): This Exploratory/Developmental Research (R21) application proposes to study the phenomenon of turbidity suppression optical phase conjugation (TS-OPC) and explore its uses for biomedical applications. TS-OPC - a biophotonic phenomenon recently observed by my group, is based on the use of optical phase conjugation to suppress tissue turbidity. Unlike absorption, elastic optical scattering is a time reversible process. As such, a time reversed copy of the scattered field should be able to retrace its trajectory through the scattering medium and recover the original light field. Our initial experiments revealed that this phenomenon is surprisingly robust - we were able to observe the phenomenon with a chicken tissue section of thickness 5mm and a wavelength of 532 nm. Our initial investigations also point to the potential utility of the method for several applications: optical powering of miniature sub-dermal implants, improving photodynamic therapy procedures, tissue absorption/scattering interrogation, etc. The focus of the proposed research is to attain a more complete understanding of the technique's working principle, streamline its implementation in reflection mode and begin initial investigations into its use for enhanced and targeted light delivery into tissues for photodynamic applications. The specific aims of the proposed research are: 1. Develop a quick, efficient and simple reflection mode TS-OPC system. 2. Experimentally determine the limits of the reflection mode TS-OPC method. 3. Develop a theoretical framework for understanding the TS-OPC method. 4. Begin initial investigations into the use of TS-OPC for enhanced and targeted light delivery into tissues - useful for photodynamics therapy (PDT). Narrative for Optical phase conjugation project PUBLIC HEALTH RELEVANCE: The phenomenon of turbidity suppression via optical phase conjugation can potentially be adapted for clinical diagnosis and therapeutics. The funding of the proposed research will allow us to better understand this newly discovered phenomenon and allow us to begin exploring one of its more promising applications - the enhancement of light delivery during photodynamic therapy procedures.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Biomedical TechnologyBiophotonicsChickensDermalDevelopmentExploratory/Developmental GrantFundingGoalsImplantInvestigationKnowledgeLeadLightMethodsNIH Program AnnouncementsOpticsPhasePhotochemotherapyPrincipal InvestigatorProceduresProcessResearchSystemTechniquesTherapeuticThickTimeTissuesTranslatingWorkYangabsorptionbaseclinical Diagnosisimprovedinnovationnovelprogramspublic health relevanceresearch study
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
701
DUNS Number
009584210
UEI
U2JMKHNS5TG4
Project Start Date
01-July-2008
Project End Date
31-August-2010
Budget Start Date
01-September-2009
Budget End Date
31-August-2010
Project Funding Information for 2009
Total Funding
$40,125
Direct Costs
$25,000
Indirect Costs
$15,125
Year
Funding IC
FY Total Cost by IC
2009
National Institute of Biomedical Imaging and Bioengineering
$40,125
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3R21EB008866-02S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R21EB008866-02S1
Patents
No Patents information available for 3R21EB008866-02S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R21EB008866-02S1
Clinical Studies
No Clinical Studies information available for 3R21EB008866-02S1
News and More
Related News Releases
No news release information available for 3R21EB008866-02S1
History
No Historical information available for 3R21EB008866-02S1
Similar Projects
No Similar Projects information available for 3R21EB008866-02S1